Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You have been diagnosed with a type of lung cancer called non-small cell lung cancer (NSCLC) — specifically adenocarcinoma, squamous cell carcinoma, or large cell carcinoma — confirmed by a tissue biopsy or pathology test.
- A special type of scan called a PET-CT has shown that your lung cancer has spread to lymph nodes on the opposite side of your chest from the main tumour (known as N3 stage).
- You are between 18 and 75 years old.
- Your heart and lungs are working well enough to safely undergo surgery, including having a heart pumping function (LVEF) of at least 45% and a breathing test result (FEV1) of at least 50% of the expected value for someone your age and size.
- Doctors have reviewed your scans and determined that your tumour can be surgically removed, along with lymph nodes on both sides of your chest.
- Scans of your whole body show no signs that the cancer has spread to other parts of the body (no distant metastasis).
- You are generally in good physical health and able to carry out your normal daily activities independently (this is measured by a scoring system called ECOG, with a score of 0 or 1).
- You and your family are willing to sign a consent form after being fully informed about the study, including its purpose, risks, and potential benefits.
Who may not be able to join:
- Your tumour cannot be fully removed by surgery, for example because it has grown into major blood vessels, the spine, or the heart.
- You have serious heart or lung conditions, such as heart failure, a previous heart attack, irregular heartbeat, severe asthma, or other uncontrolled long-term illnesses that make surgery unsafe.
- Your scans show that the cancer has already spread to other organs, such as the liver, bones, or brain.
- You have a known severe allergy to anaesthetic drugs, or your heart or lung health makes anaesthesia too risky.
- You are currently pregnant or breastfeeding.
- You have a psychiatric condition or are otherwise unable to fully understand and agree to the study's consent process independently.
- You are unable to attend follow-up appointments after surgery, for example due to living too far from the hospital or other practical barriers.
- You have another type of cancer in addition to lung cancer, particularly one with a high risk of coming back.
- You have a known immune system disorder or severe immunodeficiency, including HIV, or you have had an organ transplant.
- You are an older adult with multiple chronic health problems or declining physical function that makes surgery or anaesthesia too risky (confirm with trial site).
- You have severe liver disease (such as cirrhosis) or kidney failure that could prevent you from safely having surgery or recovering from it.
- You currently have an active infection, such as pneumonia, tuberculosis, or bacterial infection being treated with antibiotics.
- You have diabetes with poorly controlled blood sugar or serious diabetes-related complications, such as problems with your feet or eyesight.
- You are currently taking part in another clinical trial that could interfere with this study's treatments.
- You are significantly malnourished or have experienced serious unintended weight loss that could affect your recovery from surgery.
- You have a serious blood disorder, such as very low red blood cell counts (anaemia) or low platelet counts, which could cause problems with bleeding during or after surgery.
- You are dependent on a ventilator or have had a tracheostomy (a surgical opening in the throat for breathing) due to severe long-term breathing failure.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Evaluation of the Efficacy of Primary Tumor Resection Combined with Bilateral Lymph Node Dissection in Non-Small Cell Lung Cancer Patients with Contralateral Thoracic Lymph Node Metastasis
Can't join this trial?
Data last synced from ClinicalTrials.gov: 2 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.